The report says Mastek delivered healthy revenue growth but missed on margins in Q2FY27, maintaining BUY with a TP of INR 1,920.
Read this note →Mastek Limited
NSE MASTEK BSE 523704 INE759A01021
0 filings · 0 analysed
1,500.60
-8.76%
over 6 months
-
HSIE Results Daily 27 Oct 26 HSIE
The report says Mastek delivered healthy revenue growth but missed on margins in Q2FY27, maintaining BUY with a TP of INR 1,920.
-
The report lists Mastek in its valuation comparison table without specific commentary on the PERM issue.
-
The note expects Mastek to grow +1.7% QoQ CC and cuts its target price from INR 2,080 to INR 1,920 on a lower 12x multiple.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
Targets, and what happened next
What each house published, and where the price has gone since. Orivam issues no calls of its own and takes no view on these.
| House | Published | Call | Entry | Target | Now | Progress | Standing |
|---|---|---|---|---|---|---|---|
| HDFC Securities | 01 Oct 2026, 16:10 | long | 1,555.60 | 1,920.00 | 1,476.70 | -22% | open by 2027-10-01 |
Deadlines: 0 stated by the house, the rest set by Orivam’s convention — ten trading days for a technical call, twelve months for a price target. A target with no date cannot be judged, so one has to be chosen.
What the desks said
The report lists Mastek in its valuation comparison table without specific commentary on the PERM issue.
Read this note →The note expects Mastek to grow +1.7% QoQ CC and cuts its target price from INR 2,080 to INR 1,920 on a lower 12x multiple.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief